6ix — Find Your Next Investment

Discover investor relations events, company profiles, and opportunities on 6ix. Connect with public companies and attend live investor events.

Please enable JavaScript to use all features of 6ix.com.

Latest Press Releases

Time	Headline
18m ago	CC Capital and OneIM Complete Acquisition of Insignia Financial Limited, Australia's Leading Diversified Wealth Management Group
51m ago	Canadian Gold Resources Strengthens Board with Capital Markets Veteran Kenneth Chernin
51m ago	Waraba Gold Signs Binding Agreement to Establish Joint Venture Relating to Tengrela South Exploration Permit Application in Cote d'Ivoire
51m ago	Sierra Madre Announces Shareholder Approval of Acquisition of Del Toro Silver Mine
51m ago	First Quantum Minerals Reports First Quarter 2026 Results

About

Lexeo Therapeutics, Inc. Common Stock (NASDAQ:LXEO) — investor relations, events, news, and company updates on 6ix.

Latest News

Lexeo Therapeutics Announces Multiple Presentations at the 29th American Society of Gene & Cell Therapy (ASGCT) Annual Meeting

Lexeo Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Operational Highlights

Lexeo Therapeutics to Participate in the Leerink Global Healthcare Conference

Lexeo Therapeutics to Participate in Upcoming Investor Conferences in February

Lexeo Therapeutics Announces Key Leadership Appointments Strengthening Cardiovascular Expertise Alongside Updates to Strategic Partnership for Novel Cardiac RNA Therapeutics

Financials

Revenue

$0

Market Cap

$427.48 M

EPS

-1.86

Community Chat

Ask AI